Literature DB >> 197538

Cell-mediated cytotoxicity in recurrent herpes simplex virus infections in man.

R C Reichman, R Dolin, M M Vincent, A S Fauci.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 197538     DOI: 10.3181/00379727-155-39853

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  8 in total

1.  Lymphocyte-derived chemotactic factor synthesis in initial genital herpesvirus infection: correlation with lymphocyte transformation.

Authors:  M C Rattray; G M Peterman; L C Altman; L Corey; K K Holmes
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

2.  Neutralising antibody in mice with primary and recurrent herpes simplex virus infection.

Authors:  J M Darville; W A Blyth
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

3.  Murine cellular cytotoxicity to syngeneic and xenogeneic herpes simplex virus-infected cells.

Authors:  S Kohl; D B Drath; L S Loo
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

4.  Immunity to herpes simplex virus type 2: cell-mediated immunity in latently infected guinea pigs.

Authors:  A D Donnenberg; E Chaikof; L Aurelian
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

5.  Human antibody-dependent cellular cytotoxicity and natural killer cytotoxicity to herpes simplex virus-infected autologous and allogeneic cells.

Authors:  S Kohl; C M Moore
Journal:  Immunology       Date:  1983-01       Impact factor: 7.397

6.  Systemic immunity in herpetic keratitis.

Authors:  D L Easty; C Carter; A Funk
Journal:  Br J Ophthalmol       Date:  1981-02       Impact factor: 4.638

7.  Antibody responses in humans to individual proteins of herpes simplex viruses.

Authors:  S C Gilman; J J Docherty; W E Rawls
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

8.  In vitro studies on the human cellular immune response to commercially available herpes simplex antigens.

Authors:  B M Czarnetzki; E Macher
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.